Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
He will be leading the business, operations, P&L, and growth strategy for StanPlus
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks
South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim
The plant is expected to start commercial operations from Q4FY24
The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital
Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
Subscribe To Our Newsletter & Stay Updated
